Affinia Therapeutics Presents New Preclinical Data on Novel AAV Capsids for Skeletal Muscle, Cardiac Muscle, and CNS at the American Society of Gene & Cell Therapy 26TH Annual Meeting ...Middle East

WALTHAM, Mass., May 18, 2023 /PRNewswire/ -- Affinia Therapeutics, an innovative gene therapy company with a proprietary platform for rationally designed adeno-associated virus (AAV) vectors and gene therapies for both rare and prevalent devastating diseases, today announced the...

Hence then, the article about affinia therapeutics presents new preclinical data on novel aav capsids for skeletal muscle cardiac muscle and cns at the american society of gene cell therapy 26th annual meeting was published today ( Thursday 18/05/2023 - 02:53 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Affinia Therapeutics Presents New Preclinical Data on Novel AAV Capsids for Skeletal Muscle, Cardiac Muscle, and CNS at the American Society of Gene & Cell Therapy 26TH Annual Meeting )

Also on site :

• Israeli footballer’s role in assault on southern Lebanon sparks outrage
• ‘We can insure the ship, but we cannot insure a human life.’
• How the US memeifies its war on Iran